The study was designed to identify factors influencing the short term effect of intensive therapy on gross motor function in children with cerebral palsy or developmental delay. Retrospectively, total Gross Motor Function Measure-88 (GMFM-88) scores measured during the first and last weeks of intensive therapy were analyzed (n = 103). Good and poor responder groups were defined as those in the top and bottom 25% in terms of score difference, respectively. The GMFM-88 score increased to 4.67 ± 3.93 after 8 weeks of intensive therapy (P < 0.001). Gross Motor Function Classification System (GMFCS) level (I–II vs. IV–V; odds ratio [OR] = 7.763, 95% confidence interval [CI] = 2.177–27.682, P = 0.002) was a significant factor in a good response to therapy. Age (≥ 36 months; OR = 2.737, 95% CI = 1.003–7.471, P = 0.049) and GMFCS level (I–II vs. IV–V; OR = 0.189, 95% CI = 0.057–0.630, P = 0.007; and III vs. IV–V; OR = 0.095, 95% CI = 0.011–0.785, P = 0.029) were significantly associated with a poor response. GMFCS level is the most important prognostic factor for the effect of intensive therapy on gross motor function. In addition, age ≥ 36 months, is associated with a poor outcome.
Cerebral Palsy* ; Child* ; Classification ; Developmental Disabilities ; Early Intervention (Education) ; Humans ; Odds Ratio ; Rehabilitation ; Retrospective Studies

Persistent enterocutaneous fistula after the removal of a gastrostomy tube is an unusual complication of percutaneous endoscopic gastrostomy (PEG). The following case report describes an 81-year-old man diagnosed with stroke and dysphagia in May 2008. The patient had been using a PEG since 2008, and PEG site infection occurred in June 2013. The PEG tube was removed and a new PEG tube was inserted. Thereafter, formation of gastrocutaneous fistula around the previous infected PEG site was observed. The fistula was refractory to medical management, accompanied by long duration of fasting and peripheral alimentation. Therefore, gastrojejunostomy tube insertion via the previously inserted PEG tube was performed, under fluoroscopic guidance; this mode of management was successful. For patients who have a gastrocutaneous fistula, gastrojejunostomy tube insertion via the pre-existing PEG tube is a safe and effective alternative management for enteral feeding.
Aged, 80 and over ; Deglutition Disorders ; Enteral Nutrition ; Fasting ; Fistula* ; Gastric Bypass* ; Gastrostomy* ; Humans ; Intestinal Fistula ; Jejunostomy ; Stroke

Background & Objective: Although the clinical manifestations and outcomes of lumbosacral plexopathy have been reported, the long-term outcomes are unclear. Therefore, we investigated clinical manifestations and long-term outcomes in patients with lumbosacral plexopathy in terms of the extent and etiology of the injury. Methods: We evaluated the clinical and electrodiagnostic data and outcomes of 23 patients with lumbosacral plexopathy in a retrospective longitudinal observational study. The enrolled subjects were divided into groups according to the etiology and extent of their injuries, and the clinical outcomes of each group 1 year after onset were investigated. Outcomes were classified as full recovery, able to walk, unable to walk, and follow-up loss. Results: The right lumbosacral plexus was involved in 11 patients, left lumbosacral plexus in 8, and both in 4. Among the 27 lumbosacral plexus lesions (4 patients had bilateral lesions), the upper lumbar plexus was involved in 6 cases, lower lumbosacral plexus in 12, and the entire lumbosacral plexus in 9. Thirteen cases arose from traumatic events, and the rest were non-traumatic. When the clinical outcomes of the groups were compared, non-traumatic cases had higher rates of full recovery than did traumatic cases. Those with lesions in the upper lumbar plexus had a higher rate of full recovery than the other groups. Conclusions: Non-traumatic etiology and upper lumbar plexus injury were associated with better outcomes. These results will be useful when planning treatment strategies and will increase our understanding of the prognosis for lumbosacral plexopathy